Immunosuppressant External Quality Assessment

The RIQAS Immunosuppressant EQA programme has been designed to cover the analysis of Immunosuppressants in clinical laboratories. Immunosuppressants are primarily used after transplant operations to prevent the host body from rejecting donor organs.

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via
  • 12 month subscription
  • LC/MS reference values provided enabling participants to compare results to an accurately assigned value

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartParameters 
RQ915912 x 2mlMonthlyMarch4

[ddownload class="button tiny secondary" id="8239" text="Enrolment Document"]

[ddownload class="button tiny secondary" id="8237" text="Method Questionnaire"]

[ddownload class="button tiny secondary" id="2976" text="Instrument & Reagent Codes"]


  • Cyclosporin
  • Everolimus
  • Sirolimus
  • Tacrolimus
Clinical Laboratory Survey